OnCo
trialsTrialRecruiting

Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance

A phase 2 trial of Flotufolastat F-18 in Prostate cancer, run by Icahn School of Medicine at Mount Sinai, now recruiting.